ALEC
Price
$5.08
Change
-$0.03 (-0.59%)
Updated
Nov 14, 03:14 PM (EDT)
138 days until earnings call
BEAM
Price
$27.14
Change
-$0.36 (-1.31%)
Updated
Nov 14, 04:02 PM (EDT)
110 days until earnings call
Ad is loading...

ALEC vs BEAM

Header iconALEC vs BEAM Comparison
Open Charts ALEC vs BEAMBanner chart's image
Alector
Price$5.08
Change-$0.03 (-0.59%)
Volume$1.1K
CapitalizationN/A
Beam Therapeutics
Price$27.14
Change-$0.36 (-1.31%)
Volume$1.77K
CapitalizationN/A
ALEC vs BEAM Comparison Chart
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALEC vs. BEAM commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a StrongSell and BEAM is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (ALEC: $5.12 vs. BEAM: $27.50)
Brand notoriety: ALEC and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 102% vs. BEAM: 83%
Market capitalization -- ALEC: $501.41M vs. BEAM: $2.31B
ALEC [@Biotechnology] is valued at $501.41M. BEAM’s [@Biotechnology] market capitalization is $2.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 6 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ALEC’s TA Score: 6 bullish, 4 bearish.
  • BEAM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ALEC is a better buy in the short-term than BEAM.

Price Growth

ALEC (@Biotechnology) experienced а -2.29% price change this week, while BEAM (@Biotechnology) price change was +3.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.82%. For the same industry, the average monthly price growth was +4.53%, and the average quarterly price growth was +7.12%.

Reported Earning Dates

ALEC is expected to report earnings on Apr 01, 2025.

BEAM is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-0.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.31B) has a higher market cap than ALEC($501M). BEAM YTD gains are higher at: 1.029 vs. ALEC (-35.840). BEAM has higher annual earnings (EBITDA): -162.88M vs. ALEC (-178.26M). BEAM has more cash in the bank: 1.01B vs. ALEC (503M). ALEC has less debt than BEAM: ALEC (36.1M) vs BEAM (165M). BEAM has higher revenues than ALEC: BEAM (353M) vs ALEC (55.3M).
ALECBEAMALEC / BEAM
Capitalization501M2.31B22%
EBITDA-178.26M-162.88M109%
Gain YTD-35.8401.029-3,484%
P/E RatioN/AN/A-
Revenue55.3M353M16%
Total Cash503M1.01B50%
Total Debt36.1M165M22%
TECHNICAL ANALYSIS
Technical Analysis
ALECBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Ad is loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFREX9.80N/A
N/A
Schwab Fundamental Global Real Estt Idx
OIEPX26.30N/A
N/A
JPMorgan Equity Income R3
TPLGX81.81-0.09
-0.11%
T. Rowe Price Instl Large Cap Core Gr
ARSZX11.29-0.06
-0.53%
AMG River Road Small-Mid Cap Value Z
CRRYX18.22-0.11
-0.60%
Columbia Small Cap Value II Inst3

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with DNLI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
-7.75%
DNLI - ALEC
55%
Loosely correlated
-0.84%
NTLA - ALEC
53%
Loosely correlated
-3.24%
BEAM - ALEC
53%
Loosely correlated
-1.57%
PGEN - ALEC
50%
Loosely correlated
-3.57%
VERV - ALEC
49%
Loosely correlated
-9.67%
More